scispace - formally typeset
L

László Mózsik

Researcher at University of Groningen

Publications -  11
Citations -  143

László Mózsik is an academic researcher from University of Groningen. The author has contributed to research in topics: Gene cluster & Cas9. The author has an hindex of 3, co-authored 9 publications receiving 42 citations.

Papers
More filters
Journal ArticleDOI

A Penicillium rubens platform strain for secondary metabolite production

TL;DR: The penicillin BGC could be restored through in vivo assembly with eight DNA segments with short overlaps and paves the way for fast combinatorial assembly and expression of biosynthetic pathways in a fungal strain with low endogenous secondary metabolite burden.
Journal ArticleDOI

Modular Synthetic Biology Toolkit for Filamentous Fungi.

TL;DR: In this article, a collection of 96 genetic parts, characterized in Penicillium or Aspergillus species, that are compatible and interchangeable with the Modular Cloning system are presented.
Journal ArticleDOI

CRISPR-based transcriptional activation tool for silent genes in filamentous fungi

TL;DR: In this article, a nuclease-defective mutant of Cas9 (dCas9) was fused to a highly active tripartite activator VP64-p65-Rta (VPR) to allow for sgRNA directed targeted gene regulation.
Book ChapterDOI

Genome Editing in Penicillium chrysogenum Using Cas9 Ribonucleoprotein Particles.

TL;DR: This chapter describes an approach for the transformation of Penicillium chrysogenum protoplasts with preassembled ribonucleoprotein particles (RNPs) consisting of purified Cas9 protein and in vitro transcribed single guide RNA (sgRNA) for the deletion of genome sequences or their replacement with alternative sequences.
Posted ContentDOI

A Penicillium rubens platform strain for secondary metabolite production

TL;DR: The penicillin BGC could be restored through in vivo assembly with eight DNA segments with short overlaps and paves the way for fast combinatorial assembly and expression of biosynthetic pathways in a fungal strain with low endogenous secondary metabolite burden.